|1.||Besag, F M: 1 article (12/2001)|
|2.||Vasey, M: 1 article (12/2001)|
|3.||Berry, D J: 1 article (12/2001)|
|4.||Strassburg, H M: 1 article (03/2001)|
|5.||Sigler, M: 1 article (03/2001)|
|6.||Boenigk, H E: 1 article (03/2001)|
03/01/1996 - "has now had complete seizure control on methsuximide monotherapy, a total of 1200 mg a day, for 7 years with the exception of one seizure event occurring on an attempted discontinuation of methsuximide after being 5 years seizure free. "
03/01/1996 - "All five patients have been seizure free with the use of methsuximide and four out of five are now on methsuximide monotherapy with good success. "
04/01/1983 - "Methsuximide for complex partial seizures: efficacy, toxicity, clinical pharmacology, and drug interactions."
06/01/1981 - "Methsuximide appeared to be an effective and generally well tolerated adjunct medication in the management of complex partial seizures."
06/01/1981 - "Seizure control was optimal at methsuximide doses of 9.5 to 11.0 mg per kilogram per day and plasma levels of 20 to 24 micrograms per milliliter. "
03/01/2001 - "Effective and safe but forgotten: methsuximide in intractable epilepsies in childhood."
03/01/2001 - "The efficacy and safety of methsuximide (MSM) was evaluated in children with intractable epilepsies in a prospective uncontrolled study. "
07/01/1977 - "[Methsuximide in the treatment of epilepsies (author's transl)]."
03/01/1958 - "Celontin in patients with refractory epilepsy."
07/01/1957 - "Use of celontin in the treatment of mixed epilepsy."
|3.||Absence Epilepsy (Absence Seizure)
|4.||Juvenile Myoclonic Epilepsy
03/01/1996 - "Methsuximide therapy of juvenile myoclonic epilepsy."
|5.||Restless Legs Syndrome (Restless Legs)
|1.||Valproic Acid (Valproate, Semisodium)
|3.||Anticonvulsants (Antiepileptic Drugs)